805 related articles for article (PubMed ID: 33191813)
1. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Borges RC; Hohmann MS; Borghi SM
Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
[TBL] [Abstract][Full Text] [Related]
2. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
3. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R; Kalmarzi RN; Roghani SA
Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
[TBL] [Abstract][Full Text] [Related]
4. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
5. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.
Alamri A; Fisk D; Upreti D; Kung SKP
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498725
[TBL] [Abstract][Full Text] [Related]
6. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
[TBL] [Abstract][Full Text] [Related]
8. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
9. Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19.
Bernini R; Velotti F
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641348
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses and therapies against SARS-CoV-2 infection.
Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
[TBL] [Abstract][Full Text] [Related]
11. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions.
Shah M; Woo HG
Mol Cells; 2021 Jun; 44(6):408-421. PubMed ID: 34059561
[TBL] [Abstract][Full Text] [Related]
12. Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease.
Todorović-Raković N; Whitfield JR
Cytokine; 2021 Oct; 146():155637. PubMed ID: 34242899
[TBL] [Abstract][Full Text] [Related]
13. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
14. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
O'Connell P; Aldhamen YA
Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
[TBL] [Abstract][Full Text] [Related]
15. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
[TBL] [Abstract][Full Text] [Related]
17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.
van Eijk LE; Binkhorst M; Bourgonje AR; Offringa AK; Mulder DJ; Bos EM; Kolundzic N; Abdulle AE; van der Voort PH; Olde Rikkert MG; van der Hoeven JG; den Dunnen WF; Hillebrands JL; van Goor H
J Pathol; 2021 Jul; 254(4):307-331. PubMed ID: 33586189
[TBL] [Abstract][Full Text] [Related]
19. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
Kehrer T; García-Sastre A; Miorin L
J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
[TBL] [Abstract][Full Text] [Related]
20. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection.
Chang T; Yang J; Deng H; Chen D; Yang X; Tang ZH
Front Immunol; 2022; 13():843342. PubMed ID: 35265087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
